Daniel Ek's Neko Health raises $700M for health scanning technology
Neko Health, the body-scanning and health assessment startup co-founded by Spotify CEO Daniel Ek, has secured $700 million in funding. The capital infusion is intended for expansion into the U.S. market.
Neko Health, a health technology company co-founded by Spotify CEO Daniel Ek and Hjalmar Nilsonne, has raised $700 million in Series C funding. This follows a $260 million Series B round completed in January 2025.
The company utilizes proprietary body-scanning technology coupled with blood analysis to provide comprehensive health assessments. Neko Health is preparing to launch its first U.S. location in New York. The company reports that over 100,000 individuals have undergone its scanning process.
Neko Health's technology integrates with data from sources like Apple Health, offering clinicians a broader view of a patient's health status. The company's methodology has reportedly aided in early detection of potential health issues, such as a user identifying a mole for removal.
The funding round was led by Lightspeed Venture Partners and O.G. Venture Partners. Other investors include Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD. The company currently operates locations in the UK and Sweden.